Common Contracts
5 similar Securities Purchase Agreement contracts by Akanda Corp., Greenwave Technology Solutions, Inc., Inhibikase Therapeutics, Inc., others
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 20th, 2024 • Volcon, Inc. • Motor vehicles & passenger car bodies • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 20, 2024, between Volcon, Inc., a Delaware corporation (the “Company”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”)).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 20th, 2024 • Greenwave Technology Solutions, Inc. • Wholesale-metals service centers & offices • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 16, 2024, between Greenwave Technology Solutions, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 20th, 2024 • Akanda Corp. • Medicinal chemicals & botanical products • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of May __, 2024, between Akanda Corp., a Canadian corporation incorporated under the Business Corporations Act (Ontario) (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 20th, 2024 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 20, 2024, between Inhibikase Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 20th, 2024 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 14, 2024, between T2 Biosystems, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
